Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents

BACKGROUND: With advent of direct-acting antiviral agents (DAA), hepatitis C virus (HCV) treatment is dramatically increasing. Although few studies reported rates of hepatocellular carcinoma (HCC) recurrence following DAA treatment, there have been no studies that followed sufficient number of DAA-t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dig Dis Sci
Hauptverfasser: Zou, Winnie Y., Choi, Kati, Kramer, Jennifer R., Yu, Xian, Cao, Yumei, El-Serag, Hashem B., Kanwal, Fasiha
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6819241/
https://ncbi.nlm.nih.gov/pubmed/31041639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-019-05641-3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge